Amrita Pharma Private Limited
About Amrita Pharma Private Limited
Data last updated:
Amrita Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 May 2022.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2022PTC161370. Its GSTIN is 29AAXCA1345A1ZP (Karnataka).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹84.3 Lakh. It is led by directors Raman Kumaran and Asha Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹53.09 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹29.96 Lakh (net margin 0.6%) and EBITDA of ₹83.93 Lakh (EBITDA margin 1.6%).
As per MCA filings, the company has open charges of ₹9.12 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo. 9/1 Ground And First Floor, Singanayakanahalli, Bangalore, Karnataka, India – 560064
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Amrita Pharma Private Limited
The main business activity of Amrita Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Amrita Pharma Private Limited FY 2025 filings available
Amrita Pharma Private Limited reported revenue of ₹53.09 Cr (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Amrita Pharma Private Limited
Revenue rose 19% in the latest year. EBITDA rose 33% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Amrita Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹83.93 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹29.96 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Amrita Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.6% | •••• | •••• |
| Net Profit Margin | 0.6% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Amrita Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Amrita Pharma Private Limited
Amrita Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shivam Medicos Private Limited | ₹53.81 Cr (FY 2024) | •••• | •••• | 35.0% | •••• | Delhi, India |
| Lila Sales and Marketing Private Limited | ₹53.7 Cr (FY 2024) | •••• | •••• | -1.0% | •••• | Kolkata, West Bengal, India |
| Synchem Pharmaceuticals Private Limited | ₹53.59 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Indore, Madhya Pradesh, India |
| Dhana Lakshmi Private Limited | ₹53.41 Cr (FY 2022) | •••• | •••• | 35.0% | •••• | Manipur, India |
| Rhine Biogenics Private Limited | ₹53.2 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Palghat, Kerala, India |
| Amrita Pharma Private Limited this company | ₹53.09 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Bangalore, Karnataka, India |
| Indian Drug Distributors Private Limited | ₹53.01 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Mumbai, Maharashtra, India |
| B A & Brothers (Eastern) Private Ltd | ₹52.64 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Kolkata, West Bengal, India |
| Muthu Pharmacy Private Limited | ₹52.25 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Chennai, Tamil Nadu, India |
| Kaustubha Scientific Research Laboratory Private Limited | ₹52.21 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Bangalore, Karnataka, India |
| Farmachem Private Limited | ₹52.19 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Telangana, India |
Peers are the five companies nearest above and the five nearest below Amrita Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Amrita Pharma Private Limited
Amrita Pharma Private Limited is audited by PRASHANTH K N & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PRASHANTH K N & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Amrita Pharma Private Limited
Amrita Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raman Kumaran Also directs: Maa Ambika Pharma Private Limited | Director | 19 May 2022 | 4 Years 4 Months | Current |
| Asha Kumari Also directs: Amrita Pharma Sales LLP | Director | 19 May 2022 | 4 Years 4 Months | Current |
Ownership and Shareholding of Amrita Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Amrita Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Dec 2025 | Others | ₹6 Cr | Open |
| 06 Jul 2024 | Others | ₹3.12 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Amrita Pharma Private Limited
Amrita Pharma Private Limited has a workforce of 0 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Amrita Pharma Private Limited
Amrita Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Asha Kumari was appointed as Director on 19 May 2022.
Credit Ratings, Litigation & Regulatory Alerts for Amrita Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Amrita Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Amrita Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Amrita Pharma Private Limited
Amrita Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAXCA1345A1ZP | Karnataka | Active | 20 Jul 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Amrita Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amrita Pharma Private Limited
Amrita Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 May 2022 (4+ years old) and is registered under CIN U51909KA2022PTC161370.
Amrita Pharma reported revenue of ₹53.09 Cr for FY 2025 (up 19% YoY).
Amrita Pharma has 2 current directors:
- Raman Kumaran - Director
- Asha Kumari - Director
Amrita Pharma reported a net profit of ₹29.96 Lakh (net margin 0.6%) and EBITDA of ₹83.93 Lakh (EBITDA margin 1.6%) for FY 2025, as per its filed financial statements.
The GSTIN of Amrita Pharma is 29AAXCA1345A1ZP, registered in Karnataka.
The CIN (Corporate Identification Number) of Amrita Pharma is U51909KA2022PTC161370. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amrita Pharma was incorporated on 19 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Amrita Pharma by revenue are Shivam Medicos Private Limited, Lila Sales and Marketing Private Limited, Synchem Pharmaceuticals Private Limited, Dhana Lakshmi Private Limited, Rhine Biogenics Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Asha Kumari was appointed as Director on 19 May 2022. Raman Kumaran was appointed as Director on 19 May 2022.
The registered office of Amrita Pharma is at No. 91 Ground And First Floor, Singanayakanahalli, Bangalore, Karnataka, India – 560064.
Amrita Pharma has an authorised share capital of ₹1 Cr and a paid-up capital of ₹84.3 Lakh.